Gainers
- United Maritime Corporation (NASDAQ:USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
- American Rebel Holdings, Inc. (NASDAQ:AREB) gained 85% to $1.4150. American Rebel Holdings agreed to acquire Utah-based Champion Safe Company and its ancillary companies, in a transaction valued at $9.9 million.
- Grove Collaborative Holdings, Inc. (NYSE:GROV) shares jumped 66.3% to $6.65 amid news the company's products will now be available in Kohl's (NYSE:KSS), Midwest-based Meijer and also Giant Eagle.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) surged 41% to $0.54. Kiromic BioPharma completed the construction of its expanded current good manufacturing practice manufacturing facility in Houston.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 39% to $6.31.
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) jumped 30.6% to $0.2311 after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.
- Immuron Limited (NASDAQ:IMRN) gained 22% to $2.60. Immuron received European Patent notification on drug composition to treat clostridioides difficile associated disease.
- OceanPal Inc. (NASDAQ:OP) jumped 21.3% to $0.5458. OceanPal recently announced time charter contract for m/v Calipso.
- Cryptyde, Inc. (NASDAQ:TYDE) rose 19% to $1.44. Cryptyde recently disclosed a corporate roadmap for the remainder of 2022 into 2023.
- Target Hospitality Corp. (NASDAQ:TH) gained 16.7% to $5.78.
- SIGNA Sports United N.V. (NYSE:SSU) jumped 16.4% to $6.40.
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 16.1% to $5.19 after several SEC filings showed recent insider buying.
- Longeveron Inc. (NASDAQ:LGVN) shares gained 15.9% to $7.06. Longeveron said an abstract regarding the Lomecel-B Phase 2a trial in Alzheimer's Disease has been accepted for presentation at the Alzheimer's Association International Conference.
- Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) gained 15.9% to $1.7173.
- Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) gained 13.5% to $3.10. Verrica Pharmaceuticals recently priced its underwritten public offering of 12,000,000 shares at $2.10 per share.
- Accolade, Inc. (NASDAQ:ACCD) gained 13.2% to $10.47.
- Crescent Point Energy Corp. (NYSE:CPG) surged 13.1% to $7.24 after the company announced an increase to its quarterly dividend and updated FY22 guidance.
- iSpecimen Inc. (NASDAQ:ISPC) jumped 13.1% to $2.68. iSpecimen added new global biospecimen suppliers to proprietary marketplace platform for researchers to leverage.
- Veru Inc. (NASDAQ:VERU) rose 12.9% to $14.70. Veru shares gained 13% on Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for ARDS and death in The New England Journal of Medicine Evidence.
- Palisade Bio, Inc. (NASDAQ:PALI) gained 12.8% to $0.4821.
- Daqo New Energy Corp. (NYSE:DQ) jumped 12% to $74.99.
- JinkoSolar Holding Co., Ltd. (NYSE:JKS) jumped 11.3% to $72.93. JinkoSolar recently announced up to $200 million share buyback program.
- NIO Inc. (NYSE:NIO) gained 9.3% to $22.76, a day after its Nio Power Day 2022, where it announced a 500-kilowatt ultra-fast charging pile and offered a glimpse into its third-generation battery swap station.
- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) gained 8.7% to $0.2801 after gaining around 4% on Wednesday.
- ON Semiconductor Corporation (NASDAQ:ON) jumped 8.4% to $51.61 in sympathy with Samsung, which reported a 21% increase in quarterly revenue.
- MIND Technology, Inc. (NASDAQ:MIND) rose 7.8% to $0.90 after the company announced that it received orders for sonar and source controller systems totaling approximately $7.7 million.
- BioRestorative Therapies, Inc. (NASDAQ:BRTX) gained 7.8% to $3.33. BioRestorative Therapies recently enrolled first patient in the phase 2 clinical study of its lead drug BRTX-100 in chronic lumbar disc disease (cLDD).
- GameStop Corp. (NYSE:GME) rose 7% to $125.61 after the company announced a stock split.
- Alibaba Group Holding Limited (NYSE:BABA) gained 4.8% to $124.85. China's cyberspace regulator informed that rules requiring data exports to undergo security reviews would be effective from September 1, Reuters reported.
Losers
- Integrated Media Technology Limited (NASDAQ:IMTE) shares tumbled 59.8% to $2.10.
- DiaMedica Therapeutics Inc. (NASDAQ:DMAC) shares dipped 37.7% to $1.2595 after the company announced the FDA has placed a clinical hold on its Phase 2/3 ReMEDy2 trial for DM199.
- CytomX Therapeutics, Inc. (NASDAQ:CTMX) fell 29.4% to $1.39 after the company reported Phase 2 results for praluzatamab ravtansine in breast cancer. Piper Sandler and Mizuho downgraded the stock also.
- Avalo Therapeutics, Inc. (NASDAQ:AVTX) dipped 23.7% to $0.4155. Avalo Therapeutics announced one-for-twelve reverse stock split.
- Waitr Holdings Inc. (NASDAQ:WTRH) shares fell 22.3% to $0.2062 after jumping 73% on Wednesday.
- USANA Health Sciences, Inc. (NYSE:USNA) fell 16% to $64.29 after the company reported preliminary second-quarter results and updated its FY22 outlook. The company said it expects net sales of $1.015 billion- $1.065 billion, versus prior guidance of $1.1 billion - $1.2 billion. It also sees EPS of $3.85 - $4.45, compared to prior guidance of $5.00 - $5.70.
- BioVie Inc. (NASDAQ:BIVI) fell 13.9% to $1.67.
- Enjoy Technology, Inc. (NASDAQ:ENJY) shares fell 12.8% to $0.3655 after jumping 35% on Wednesday.
- Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) dipped 9.2% to $13.89. Intercept Pharmaceuticals announced positive topline results from a new interim analysis of its ongoing pivotal Phase 3 REGENERATE trial of OCA in patients with liver fibrosis due to nonalcoholic steatohepatitis (NASH).
- Revelation Biosciences, Inc. (NASDAQ:REVB) fell 9.1% to $1.0903 after jumping 44% on Wednesday.
- Helen of Troy Limited (NASDAQ:HELE) dropped 8.8% to $154.97 after the company reported worse-than-expected Q1 EPS results and cut FY23 adjusted EPS and sales guidance below estimates.
- The Duckhorn Portfolio, Inc. (NASDAQ:NAPA) fell 8.1% to $19.06 after the company reported a secondary offering of 5,000,000 shares of common stock.
- IperionX Limited (NASDAQ:IPX) fell 8% to $4.4999.
- Revlon, Inc. (NYSE:REV) dropped 7.9% to $5.84 on continued post-bankruptcy volatility.
- IN8bio, Inc. (NASDAQ:INAB) dropped 7.6% to $2.18.
- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) fell 7.2% to $0.8350. Titan Pharmaceuticals shares jumped 49% on Wednesday after the company announced FDA clearance of its IND application for nalmefene implant.
- Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) fell 6.7% to $2.22. Art's-Way Manufacturing recently posted Q2 EPS of $0.04.
